Alvotech SA (ALVO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec22

Alvotech and Advanz Pharma Collaborate to Launch Gobivaz® in Europe

07:02

Dec19

Alvotech and Teva Reach Settlement with Regeneron for AVT06 US Launch

08:32

Dec17

Alvotech SA Issued Bonds and Expanded Production Scale

07:30

Nov24

Alvotech Announces AVT03 Approval in the European Economic Area

10:58

Nov20

Alvotech and Advanz Pharma Obtain Gobivaz® Approval in the European Economic Area

09:00

Nov14

Northland Securities Analyst Maintains Buy Rating on Alvotech

15:22

Schedules & Filings

Schedules

Filings

Nov12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 113.86 M, Net Income -5.252 M, EPS -0.0175

Aug13

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 173.34 M, Net Income 32.04 M, EPS 0.1042

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 132.81 M, Net Income 109.68 M, EPS 0.35

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change